FIELD: biotechnology.
SUBSTANCE: invention relates to the field of biotechnology, specifically to a set of peptides, and can be used in medicine. The peptides included in the set are able to specifically bind with antibodies in the blood plasma of patients diagnosed with breast cancer (BC) while ensuring detection of antibodies in the blood plasma of patients with BC. By the presence of increased or reduced production of antibodies to the panel of 119 peptides presented in the invention, donors diagnosed with BC can be distinguished from donors without BC.
EFFECT: present invention can be used in immunology and oncology for diagnostics/screening of malignant breast tumours; the proposed invention can also be used in addition to methods for diagnostics of breast cancer for improving sensitivity and specificity, and in combination with other analytical systems for improving efficiency of diagnostics of BC.
1 cl, 4 dwg, 1 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
ANTI-TIGIT ANTIBODIES AND METHODS OF USING | 2016 |
|
RU2732591C2 |
NOVEL PEPTIDES AND PEPTIDE COMBINATIONS FOR USE IN IMMUNOTHERAPY OF LUNG CANCER, INCLUDING NON-SMALL CELL LUNG CANCER (NSCLC) AND OTHER CANCERS | 2016 |
|
RU2723092C2 |
ANTIBODY AGENTS SPECIFIC TO HUMAN CD19, AND THEIR APPLICATIONS | 2016 |
|
RU2773317C2 |
METHODS AND SETS RELATED TO CAPTURE OF CA-IX-POSITIVE EXOSOMES | 2018 |
|
RU2770592C2 |
HUMANIZED ANTIBODIES AND ANTIBODIES WITH MATURE AFFINITY AGAINST FcRH5 AND METHODS FOR THEIR APPLICATION | 2016 |
|
RU2748943C2 |
NEW TUMOUR BIOMARKER | 2010 |
|
RU2714750C2 |
NEIL3 PEPTIDES AND VACCINES COMPRISING THEM | 2010 |
|
RU2733985C2 |
PEPTIDES AND PEPTIDOMIMETICS IN COMBINATION WITH CONTROL POINT INHIBITING AGENTS FOR TREATING CANCER | 2016 |
|
RU2739201C2 |
METHOD FOR DIAGNOSIS OF DISEASE ACCOMPANIED BY INCREASED CELL DEATH, AND SET FOR ITS IMPLEMENTATION | 2016 |
|
RU2630648C2 |
PEPTIDE, OBTAINED FROM MPHOSPH1, AND INCLUDING ITS VACCINE | 2016 |
|
RU2731099C2 |
Authors
Dates
2021-06-28—Published
2020-07-13—Filed